FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/04/065474 [Registered on: 09/04/2024] Trial Registered Prospectively
Last Modified On: 04/04/2024
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Other (Specify) [Texy messaging]  
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Text Messaging in first episode psychosis  
Scientific Title of Study   Effect of text message reminders on treatment retention rates among outpatients with first episode psychosis: A randomized controlled trial  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Vikas Menon  
Designation  Professor 
Affiliation  Jawaharlal Institute of Postgraduate Medical Education and Research(JIPMER) 
Address  Dept of Psychiatry, Jawaharlal Institute of Postgraduate Medical Education and Research(JIPMER), Puducherry- 605005

Pondicherry
PONDICHERRY
605006
India 
Phone  8098158528  
Fax    
Email  drvmemon@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Vikas Menon  
Designation  Professor 
Affiliation  Jawaharlal Institute of Postgraduate Medical Education and Research(JIPMER) 
Address  Dept of Psychiatry, Jawaharlal Institute of Postgraduate Medical Education and Research(JIPMER), Puducherry- 605005

Pondicherry
PONDICHERRY
605006
India 
Phone  8098158528  
Fax    
Email  drvmemon@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Vikas Menon  
Designation  Professor 
Affiliation  JIPMER 
Address  Dept of Psychiatry, Jawaharlal Institute of Postgraduate Medical Education and Research(JIPMER), Puducherry- 605005

Pondicherry
PONDICHERRY
605006
India 
Phone  8098158528  
Fax    
Email  drvmemon@gmail.com  
 
Source of Monetary or Material Support  
Jawaharlal Institute of Post Graduate Medical Education and Research, GORIMEDU, PONDICHERRY -605006 
 
Primary Sponsor  
Name  JIPMER 
Address  JIPMER, GORIMEDU, PONDICHERRY -605006 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sharmi B  Jawaharlal Institute of Postgraduate Medical Education and Research(JIPMER), Pondicherry  Room No 74, Dept of Psychiatry, Old Hospital Building, JIPMER, Gorimedu, Dhanvantari nagar, Puducherry - 605006
Pondicherry
PONDICHERRY 
9080612761

sharmibascarane@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institute Ethics Committee Interventional Studies CDSCO Reg No : ECR/342/Inst/PY/2013/RR-19  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: F30-F39||Mood [affective] disorders, (2) ICD-10 Condition: F20-F29||Schizophrenia, schizotypal, delusional, and other non-mood psychotic disorders,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Control group   The control group will not receive the text messages. The control group will be followed till the end of study period. 
Intervention  Intervention group  The intervention consists of sending text message reminders to intervention group 3 days and 5 days prior to the next follow up visit. The expected frequency of follow up of patients is once in two to three weeks. Fixed frequency text message reminders will be sent for medication adherence on Monday and thursday of every week. The text messages will be sent for 6 months and will be continued till the end of the study period until the last patient is recruited and followed up for 6 months 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  40.00 Year(s)
Gender  Both 
Details  Patients in the age group 18 to 40 years presenting to JIPMER with first episode of psychosis with duration of illness less than 12 months and less than four weeks of treatment with antipsychotic, antidepressant, or mood stabilizer regardless of recovery.
 
 
ExclusionCriteria 
Details  1. Caregivers without access to mobile phones
2. Caregivers who cannot read Tamil or english
3. Patients with organic psychosis
4. Psychosis due to substance use
5. Refusal to give informed consent  
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Centralized 
Blinding/Masking   Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
Text message reminder intervention increases the time to dropout among patients with first episode psychosis compared to treatment as usual  6 MONTHS 
 
Secondary Outcome  
Outcome  TimePoints 
Medication adherence, insight, social and occupational functioning   Baseline,1, 3 and 6 months 
 
Target Sample Size   Total Sample Size="300"
Sample Size from India="300" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   20/04/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="3"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Eligible patients satisfying inclusion criteria will be consented for study purposes. Since this is a pilot RCT, sample size has not been calculated as it is difficult to predict the dropout rates and patients will be recruited till the end of the study period. After baseline assessment, the participants will be randomly assigned into the control and intervention groups. SMS reminders for treatment appointment and medication adherence, at a frequency described before, will be sent to the intervention group. Outcome measures such as time to drop out (primary outcome) will be assessed over the follow-up period of 6 months, along with medication adherence, functioning, and insight (secondary outcomes) at 1,3 and 6 months. For the statistical analysis, survival analysis using cox proportional hazards regression will be done with group assignment as the primary variable of interest and the following as co-variates, subject to there being at least 10 events per independent variable:

1.     Distance from hospital

2.     Living with parents

3.     Regular employment

4.     Baseline psychopathology

5.     Insight

6.     Substance use

7.     Family emergencies

8.     Education

9.     Age

10.  Sex

 

 
Close